Abstract
For patients with variant angina it is very important to start medical therapy using calcium-channel blockers. However, the decision of physicians regarding whether to decrease the dose of the drug or discontinue it is controversial. We investigated whether the nature of spasm is remissive and whether the termination of medications is safe. The subjects studied were included in the Vasospastic Angina in Catholic Medical Center Registry from March 2001 to December 2009. We analyzed 37 patients (62 lesions) with variant angina, diagnosed using coronary angiography (CAG) and he acetylcholine provocation test, without any organic coronary stenosis, whose symptoms were well controlled after medication. The follow-up CAG with provocation test was performed at a median interval of 44 months. The characteristics of spasm were analyzed on each pair of CAGs. The study group consisted of 23 men (62.2 %) and 14 women (37.8 %) with a mean age of 59 ± 11.1 years. The follow-up CAG with provocation test showed that the characteristics of the spasmodic nature were consistent with the first test in all patients. Although the patients with variant angina had no chest pain after medical treatment, the spasmodic nature of coronary arteries still remained. We may decrease the drug dosage after carefully checking the patient’s symptoms but recommend not discontinuing therapy, even if the patient is asymptomatic.
Similar content being viewed by others
References
Yasue H (1980) Pathophysiology and treatment of coronary arterial spasm. Chest 78:216–223
Conti CR (1983) Coronary-artery spasm and myocardial infarction. N Engl J Med 309:238–239
Scholl JM, Veau P, Benacerraf A, Brau J, Hennetier G, Achard F (1988) Long-term prognosis of medically treated patients with vasospastic angina and no fixed significant coronary atherosclerosis. Am Heart J 115:559–564
Mayer S, Hillis LD (1998) Prinzmetal’s variant angina. Clin Cardiol 21:243–246
Maseri A, Severi S, Nes MD, L’Abbate A, Chierchia S, Marzilli M, Ballestra AM, Parodi O, Biagini A, Distante A (1978) “Variant” angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. Am J Cardiol 42:1019–1035
Chahine RA, Raizner AE, Ishimori T, Luchi RJ, McIntosh HD (1975) The incidence and clinical implications of coronary artery spasm. Circulation 52:972–978
Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S (1979) Circadian variation of exercise capacity in patients with Prinzmetal’s variant angina: role of exercise-induced coronary arterial spasm. Circulation 59:938–948
Lombardi M, Morales MA, Michelassi C, Moscarelli E, Distante A, L’Abbate A (1993) Efficacy of isosorbide-5-mononitrate versus nifedipine in preventing spontaneous and ergonovine-induced myocardial ischaemia. A double-blind, placebo-controlled study. Eur Heart J 14:845–851
Schroeder JS, Feldman RL, Giles TD, Friedman MJ, DeMaria AN, Kinney EL, Mallon SM, Pit B, Meyer R, Basta LL, Curry RC Jr, Groves BM, MacAlpin RN (1982) Multiclinic controlled trial of diltiazem for Prinzmetal’s angina. Am J Med 72:227–232
CASS principal investigators and their associates (1983) Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation 68:939–950
Bertrand ME, LaBlanche JM, Tilmant PY, Thieuleux FA, Delforge MR, Carre AG, Asseman P, Berzin B, Libersa C, Laurent JM (1982) Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 65:1299–1306
Yasue H, Kugiyama K (1990) Coronary artery spasm: Japanese view. Coron Artery Dis 1:668–673
Waters DD, Bouchard A, Théroux P (1983) Spontaneous remission is a frequent outcome of variant angina. J Am Coll Cardiol 2:195–199
Previtali M, Panciroli C, De Ponti R, Chimienti M, Montemartini C, Salerno JA (1989) Time-related decrease in sensitivity to ergonovine in patients with variant angina. Am Heart J 117:92–99
Ogawa T, Komukai K, Ogawa K, Kosuga T, Nagoshi T, Minai K, Sakamoto H, Hashimoto K, Yoshida S, Taniguchi I, Mochizuki S, Yoshimura M (2009) High incidence of repeat anginal attacks despite treatment with calcium-channel blockers in patients with coronary spastic angina. Circ J 73:512–515
Beltrame JF, Sasayama S, Maseri A (1999) Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol 33:1442–1452
Maseri A, Kaski JC (1989) Pathogenetic mechanisms of coronary artery spasm. J Am Coll Cardiol 14:610–612
Yamagishi M, Miyatake K, Tamai J, Nakatani S, Koyama J, Nissen SE (1994) Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. J Am Coll Cardiol 23:352–357
Shimokawa H, Nagasawa K, Irie T, Egashira S, Egashira K, Sagara T, Kikuchi Y, Nakamura M (1988) Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between western and Japanese populations. Int J Cardiol 18:331–349
Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, Cianflone D, Sanna T, Sasayama S, Maseri A (2000) Major racial differences in coronary constrictor response between Japanese and Caucasian with recent myocardial infarction. Circulation 101:1102–1108
Okumura K, Yasue H, Horio Y, Takaoka K, Matsuyama K, Kugiyama K, Fujii H, Morikami Y (1988) Multivessel coronary spasm in patients with variant angina: a study with intracoronary injection of acetylcholine. Circulation 77:535–542
Miwa K, Fujita M, Sasayama S (2005) Recent insights into the mechanisms, predisposing factors, and racial differences of coronary vasospasm. Heart Vessels 20:1–7
Koizumi T, Yokoyama M, Namikawa S, Kuriyama N, Nameki M, Nakayama T, Kaneda H, Sudhir K, Yock PG, Komiyama N, Fitzgerald PJ (2006) Location of focal vasospasm provoked by ergonovine maleate within coronary arteries in patients with vasospastic angina pectoris. Am J Cardiol 97:1322–1325
Kaski JC, Maseri A, Vejar M, Crea F, Hackett D (1989) Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus. J Am Coll Cardiol 14:1456–1463
Yasue H, Kugiyama K (1997) Coronary spasm: clinical features and pathogenesis. Intern Med 36:760–765
Shimokawa H (2000) Cellular and molecular mechanisms of coronary artery spasm—lessons from animal models. Jpn Circ J 64:1–12
Vanhoutte PM (2003) Endothelial control of vasomotor function: from health to coronary disease. Circ J 67:572–575
Kawashima S, Yokoyama M (2004) Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol 24:998–1005
Wada T, Abe M, Yagi N, Kokubu N, Kasahara Y, Kataoka Y, Otsuka Y, Goto Y, Nonogi H (2010) Coronary vasospasm secondary to allergic reaction following food ingestion: a case of type I variant Kounis syndrome. Heart Vessels 25:263–266
Takatsu F, Nishiyama A, Shiga Y, Watarai M, Shimizu S (1994) Long-term follow-up of coronary narrowing with spasm. Int J Cardiol 47:S27–S31
Bory M, Pierron F, Panagides D, Bonnet JL, Yvorra S, Desfossez L (1996) Coronary artery spasm in patients with normal or near normal coronary arteries. Long-term follow-up of 277 patients. Eur Heart J 17:1015–1021
Chen SM, Tsai TH, Hang CL, Yip HK, Fang CY, Wu CJ, Guo GB (2011) Endothelial dysfunction in young patients with acute ST-elevation myocardial infarction. Heart Vessels 26:2–9
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seo, S.M., Kim, P.J., Shin, D.I. et al. Persistent coronary artery spasm documented by follow-up coronary angiography in patients with symptomatic remission of variant angina. Heart Vessels 28, 301–307 (2013). https://doi.org/10.1007/s00380-012-0249-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-012-0249-2